OTLC insider buying and SEC filings, explained
Oncotelic Therapeutics, Inc. · CIK 908259
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Company profile
- Exchanges
- OTC
- Industry (SIC)
- Pharmaceutical Preparations
- State of incorporation
- DE
- Fiscal year end
- Dec 31
- Former names
- MATEON THERAPEUTICS INC; OXIGENE INC
Insider activity in the last 12 months
Bought
$51K
Insiders who bought
1
Sold (not marked 10b5-1)
$0
Planned sales (10b5-1)
$0
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Oct 28–29, 2026 | Open-market purchase | Vuong Trieu (CEO and Director) bought 1,356,990 shares between Oct 28 and Oct 29 at about $0.0173 ($24K) in an open-market purchase. Holdings up 1% to 95,481,309 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Oct 30, 2026, 9:00 AM ET |
| Jul 1, 2026 | Open-market purchase | Vuong Trieu (CEO and Director) bought 240,000 shares at $0.0400 ($10K) in an open-market purchase. Holdings up <1% to 94,124,319 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jul 2, 2026 |
| Jun 22–24, 2026 | Open-market purchase | Vuong Trieu (CEO and Director) bought 255,000 shares between Jun 22 and Jun 24 at $0.0500 ($13K) in an open-market purchase. Holdings up <1% to 93,884,319 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jun 24, 2026 |
| Jun 22, 2026 | Open-market purchase | Amit B. Shah (CFO) bought 20,000 shares at $0.0500 ($1K) in an open-market purchase. Holdings up 6% to 378,837 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jun 22, 2026 |
| Jun 15–17, 2026 | Open-market purchase | Vuong Trieu (CEO and Director) bought 335,759 shares between Jun 15 and Jun 17 at about $0.0429 ($14K) in an open-market purchase. Holdings up <1% to 93,629,319 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jun 17, 2026 |
8 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow OTLC in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.